Pacira BioSciences' Consolidated Net Income rose 103.79% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 123.63%. This contributed to the annual value of -$99.6 million for FY2024, which is 337.30% down from last year.
Latest data reveals that Pacira BioSciences reported Consolidated Net Income of $5.4 million as of Q3 2025, which was up 212.07% from -$4.8 million recorded in Q2 2025.
Pacira BioSciences' 5-year Consolidated Net Income high stood at $25.8 million for Q2 2023, and its period low was -$143.5 million during Q3 2024.
Moreover, its 3-year median value for Consolidated Net Income was $9.0 million (2024), whereas its average is -$4.7 million.
In the last 5 years, Pacira BioSciences' Consolidated Net Income spiked by 1,666.81% in 2023 and then crashed by 1,421.29% in 2024.
Quarterly analysis of 5 years shows Pacira BioSciences' Consolidated Net Income stood at -$5.1 million in 2021, then tumbled by 96.92% to -$10.1 million in 2022, then spiked by 346.19% to $24.9 million in 2023, then tumbled by 35.50% to $16.0 million in 2024, then skyrocketed by 103.79% to $5.4 million in 2025.
Its last three reported values are $5.4 million in Q3 2025, -$4.8 million for Q2 2025, and $4.8 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value